| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $860.8M | +7.5% |
| Cost of Revenue | $461.1M | +3.7% |
| Gross Profit | $399.7M | +12.1% |
| R&D Expense | $35.0M | +10.4% |
| SG&A Expense | $341.1M | +0.3% |
| Operating Income | $24.8M | +213.2% |
| Pre-tax Income | -$33.9M | +67.8% |
| Income Tax | $2.7M | +140.9% |
| Net Income | -$36.1M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $175.2M | +36.0% |
| Accounts Receivable | $177.7M | +3.1% |
| Inventory | $133.2M | -7.6% |
| Current Assets | $594.7M | +10.4% |
| Total Assets | $2.64B | -3.0% |
| Current Liabilities | $263.4M | -0.9% |
| Long-term Debt | $686.4M | +0.1% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $99.1M | +4.1% |
| Capital Expenditures | $48.8M | +31.5% |
| Investing Cash Flow | -$43.7M | +32.5% |
| Financing Cash Flow | -$3.3M | -114.6% |
| Free Cash Flow | $50.3M | -13.4% |
| +62.7% |
| EPS (Basic) | -$0.18 | +63.3% |
| EPS (Diluted) | -$0.18 | +63.3% |
| Total Liabilities |
| $1.08B |
| -7.8% |
| Stockholders' Equity | $1.51B | +1.4% |